Evolent files audited 2022 financials of acquired Magellan Specialty Health

Evolent Health, Inc.

Magellan Specialty Health reported 2022 net revenue of $255.3M and net income of $42.3M.
Total assets as of Dec 31, 2022 were $161.8M, including $113.2M of goodwill.
Acquisition closed Jan 20, 2023; pro forma combined info for year-end 2022 and 9M 2023 also furnished.

item 8.01 item 9.01

Evolent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628908-23-000169

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.